Skip to content

GAPP 1 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Diabetes Mellitus

GAPP 1 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Diabetes Mellitus

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01950650
Enrollment
1800
Registered
2013-09-25
Start date
2010-03-31
Completion date
2010-09-30
Last updated
2017-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2

Brief summary

This study is conducted in Asia, Europe and in the United States of America. The aim of this study is to examine patient and physician beliefs regarding insulin therapy and the degree to which patients adhere to their insulin regimens.

Interventions

BEHAVIORALNo treatment given

Survey conducted through computer-assisted telephone interviewing.

BEHAVIORALsurvey

Survey conducted via the Internet.

Sponsors

Novo Nordisk A/S
Lead SponsorINDUSTRY

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* PATIENTS WITH DIABETES: * Age 18 years or older * Treated with insulin * Type 1 or Type 2 diabetes * PHYSICIANS: * In practice for more than 1 year since completing residency * See a minimum number of patients with diabetes per week (primary care physicians 5, specialists 10) * Initiate insulin treatment for patients with diabetes

Design outcomes

Primary

MeasureTime frame
Frequency of insulin omission/non-adherenceIn the past 30 days prior to the day when responding to the survey (patient survey)
Reasons for insulin omission/non-adherence reported by patient and physicianDay 1 (when responding to the survey)

Secondary

MeasureTime frame
Impact of insulin treatment on life domains (patient survey)Day 1 (when responding to the online questionnaire)

Countries

China, France, Germany, India, Japan, Russia, Spain, Turkey (Türkiye), United Kingdom, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026